CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Aspira Pathlab & Diagnostics Ltd.

NSE : BSE : 540788 ISIN CODE : INE500C01017Industry : Hospitals & Medical Services

News

  • Aspira Pathlab & Dia has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025 16 Jan 2026 | 19:00 | Dion Global

    As of December 2025 18.39% is owned by Indian Promoters and 81.61% by Public. Top four Promoters holding highest number of shares of Aspira Pathlab &...more...

  • Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 07 Jan 2026 | 17:04 | Dion Global

    Compliance Certificate under reg 74(5) of SEBI (DP) Regulations 2018 for the quarter ended December 31 2025more...

  • Aspira Pathlab & Dia - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 06 Jan 2026 | 17:09 | Dion Global

    Intimation of Postal Ballot Notice for appointment of Mrs. Kiran Awasthi (DIN:09066721) as an Independent Director for the first term of 5 consecutiv...more...

  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Demise 05 Jan 2026 | 19:02 | Dion Global

    Revised disclosure pertaining to the demise of Dr. Alaka Keshav Deshapande pursuant to the observation email received from BSEmore...

  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Demise 02 Jan 2026 | 20:57 | Dion Global

    Demise of Independent Director - Dr. Alaka Keshav Deshpande (DIN:11238406)more...

  • Aspira Pathlab & Dia Q2 net profit jumps 85.86% at Rs 1.84 cr 13 Nov 2025 | 10:33 | Dion Global

    The company reported standalone net profit of Rs 1.84 crore for the quarter ended September 30 2025 as compared to Rs 0.99 crore in the same...more...

  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Change in Directorate 12 Nov 2025 | 21:36 | Dion Global

    Appointment of Mrs. Kiran Raghavendra Awsathi (DIN:09066721) as Additional Independent Director subject to the members approval.more...

  • Aspira Pathlab & Dia - Standalone Financial Results And Limited Review Report As On September 30, 2025 12 Nov 2025 | 21:19 | Dion Global

    The Company has acquired the business undertaking of Aspira DNA Diagnostics Gujarat LLP on a slump sale basis pursuant to the BTA Agreement ...more...

  • Aspira Pathlab & Dia - Board Meeting Outcome for Outcome Of Board Meeting Held On November 12, 2025 12 Nov 2025 | 20:23 | Dion Global

    Outcome of Board Meeting held on November 12 2025more...

  • Aspira Pathlab & Dia - Board Meeting Intimation for The Board Meeting To Be Held On November 12, 2025 04 Nov 2025 | 18:51 | Dion Global

    Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter ...more...

  • Aspira Pathlab & Dia has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025 18 Oct 2025 | 16:50 | Dion Global

    As of September 2025 18.39% is owned by Indian Promoters and 81.61% by Public. Top four Promoters holding highest number of shares of Aspira Pathlab ...more...

  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Open Offer - Updates 13 Oct 2025 | 19:28 | Dion Global

    Announcement as per Reg 30-Letter of Offermore...

  • Aspira Pathlab & Dia - Draft Letter of Offer 13 Oct 2025 | 18:44 | Dion Global

    Aftertrade Broking Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Aspira Pathlab...more...

  • Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 07 Oct 2025 | 18:16 | Dion Global

    Compliance Certificate under reg 74 (5) of SEBI (DP) regulation 2018 for the quarter ended September 30 2025more...

  • Aspira Pathlab & Dia - Disclosure Regarding Detailed Public Statement (\DPS\) In Relation To The Open Offer To The Public Sha 06 Oct 2025 | 17:39 | Dion Global

    Disclosure regarding Detailed Public Statement (\DPS\) in relation to the Open Offer to the Public Shareholdersmore...

  • Aspira Pathlab & Dia - Detailed Public Statement 06 Oct 2025 | 14:36 | Dion Global

    Aftertrade Broking Pvt Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 13...more...

  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Cessation 27 Sep 2025 | 17:20 | Dion Global

    Cessation of Mrs. Mangala Prabhu (DIN:06450659) as Independent Director due to completion of second consecutive term w.e.f September 27 2025more...

  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer 26 Sep 2025 | 21:26 | Dion Global

    Public announcement of Open Offer for acquisition of Company Equity Sharesmore...

  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Change in Directorate 26 Sep 2025 | 20:25 | Dion Global

    Appointment of Dr. Alaka Keshav Deshpande (DIN: 11238406) as Woman Independent Director in terms of regulation 17(1A) of the SEBI (LODR) Regulations ...more...

  • Aspira Pathlab & Dia - Appointment Of Secretarial Auditor Of The Company 26 Sep 2025 | 20:17 | Dion Global

    Appointment of M/s. Nilesh A. Pradhan & Co. LLP as the Secretarial Auditor for the term of 5 (five) consecutive yearsmore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex82344.680.60%
NSE Index25342.750.66%
B500DIVL503731.322.66%
BSE 1000 10712.541.16%
BSE 100LCTMC9372.330.89%
BSE Auto 59303.150.55%

Commodity

Gold136103-0.08%
Silver2462901.83%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 91.82(0.21 %)
GBP/INR 125.69(1.67 %)
EUR/INR 109.06(1.33 %)
JPY/INR 0.59(2.16 %)
CAD/INR 66.75(0.00 %)
HKD/INR 11.75(0.00 %)